IRIS
RUSCITTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.766
EU - Europa 6.248
AS - Asia 5.838
SA - Sud America 812
Continente sconosciuto - Info sul continente non disponibili 364
AF - Africa 107
OC - Oceania 12
Totale 26.147
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.420
SG - Singapore 2.690
RU - Federazione Russa 1.463
IT - Italia 1.396
IE - Irlanda 1.395
CN - Cina 1.110
BR - Brasile 692
HK - Hong Kong 631
VN - Vietnam 555
DE - Germania 398
SE - Svezia 361
TR - Turchia 331
GB - Regno Unito 263
UA - Ucraina 228
FR - Francia 205
CA - Canada 166
FI - Finlandia 160
NL - Olanda 116
BD - Bangladesh 115
IN - India 107
JP - Giappone 77
MX - Messico 56
BE - Belgio 46
AR - Argentina 43
ZA - Sudafrica 43
LT - Lituania 38
PL - Polonia 34
ES - Italia 32
ID - Indonesia 28
CZ - Repubblica Ceca 24
IQ - Iraq 22
EC - Ecuador 21
CR - Costa Rica 20
HN - Honduras 17
KR - Corea 16
PK - Pakistan 16
VE - Venezuela 16
PH - Filippine 15
AT - Austria 14
CO - Colombia 14
GT - Guatemala 13
JM - Giamaica 13
SA - Arabia Saudita 13
IL - Israele 12
RO - Romania 12
TT - Trinidad e Tobago 12
JO - Giordania 11
MA - Marocco 11
NI - Nicaragua 11
AE - Emirati Arabi Uniti 10
EE - Estonia 10
GR - Grecia 10
TN - Tunisia 10
EU - Europa 9
MY - Malesia 9
AZ - Azerbaigian 8
CH - Svizzera 8
DZ - Algeria 8
EG - Egitto 8
UZ - Uzbekistan 8
KE - Kenya 7
LB - Libano 7
NP - Nepal 7
PR - Porto Rico 7
PY - Paraguay 7
AL - Albania 6
AU - Australia 6
BB - Barbados 6
CW - ???statistics.table.value.countryCode.CW??? 6
KZ - Kazakistan 6
BO - Bolivia 5
CL - Cile 5
GP - Guadalupe 5
KW - Kuwait 5
SV - El Salvador 5
UY - Uruguay 5
DO - Repubblica Dominicana 4
HR - Croazia 4
LU - Lussemburgo 4
MK - Macedonia 4
NZ - Nuova Zelanda 4
PE - Perù 4
SN - Senegal 4
TH - Thailandia 4
CI - Costa d'Avorio 3
DK - Danimarca 3
MM - Myanmar 3
OM - Oman 3
PT - Portogallo 3
SY - Repubblica araba siriana 3
BG - Bulgaria 2
BS - Bahamas 2
ET - Etiopia 2
GH - Ghana 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
MO - Macao, regione amministrativa speciale della Cina 2
Totale 25.765
Salva come PNG Salva come JPEG
Città #
San Jose 1.549
Dublin 1.392
Singapore 1.362
Dallas 1.225
Ashburn 1.174
Chandler 1.137
Jacksonville 942
Council Bluffs 717
Hong Kong 623
Santa Clara 615
Boardman 388
New York 340
The Dalles 319
Moscow 262
Milan 239
Los Angeles 218
Beijing 211
Izmir 208
Ho Chi Minh City 172
Princeton 162
Lawrence 161
Ann Arbor 151
Hanoi 125
Nanjing 125
Wilmington 124
Rome 104
Lauterbourg 100
L'aquila 99
Amsterdam 98
São Paulo 87
San Mateo 83
Hefei 79
Munich 79
Columbus 72
Tokyo 68
Dearborn 63
Phoenix 63
L’Aquila 62
Woodbridge 57
Orem 55
Naples 54
Chicago 52
Helsinki 52
Montreal 51
Nanchang 50
Lappeenranta 47
Miano 45
Shanghai 45
Seattle 42
Brussels 41
Atlanta 40
Houston 40
Brooklyn 39
Frankfurt am Main 38
Assago 32
Des Moines 32
Stockholm 32
Da Nang 30
Dong Ket 30
Johannesburg 30
Las Vegas 30
Mountain View 30
Shenyang 30
Kunming 29
Verona 29
Warsaw 28
Pescara 27
San Francisco 27
Manchester 26
Philadelphia 26
Denver 25
Haiphong 25
Mexico City 25
Toronto 25
Hebei 24
London 24
Washington 24
Buffalo 22
Chennai 22
North Bergen 22
Tianjin 22
Jinan 21
Rio de Janeiro 21
Brno 20
New Delhi 20
Bologna 19
Charlotte 19
Guangzhou 19
Jiaxing 19
Kitzingen 19
Mumbai 19
Ankara 18
Bari 18
Boston 18
Genoa 18
Jakarta 18
Cedar Knolls 17
Changsha 17
Falkenstein 17
Pune 17
Totale 16.828
Salva come PNG Salva come JPEG
Nome #
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 196
Unenhanced Cardiac Magnetic Resonance may improve detection and prognostication of an occult heart involvement in asymptomatic patients with systemic sclerosis 186
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 171
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 171
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 170
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 170
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 170
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 167
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 166
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 165
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 164
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 162
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 161
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 161
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 157
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 155
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 155
Cardiovascular disease in primary sjögren’s syndrome 154
Short-term effectiveness of guselkumab in psoriatic arthritis patients and axial involvement: results from a real-life multicentre cohort 151
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 151
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 151
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 151
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 151
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 150
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 145
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 144
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 144
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 143
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 142
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 142
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 142
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 140
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 140
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 140
EULAR/PReS recommendations for the diagnosis and management of Still's disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still's disease 139
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's disease 138
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 138
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 138
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 137
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 137
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 136
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 136
A comprehensive review on adult onset Still's disease 136
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 135
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 135
Nail and enthesis assessment in patients with psoriatic disease by high frequency ultrasonography: findings from a single-centre cross-sectional study 134
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 134
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 133
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 133
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 133
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 132
The Systemic Score May Identify Life‐Threatening Evolution in Still Disease: Data from the GIRRCS AOSD‐Study Group and the AIDA Network Still Disease Registry 132
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 132
Stem cell therapies for systemic sclerosis 131
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 131
Long-term Safety of Rituximab in Primary Sjögren Syndrome: The Experience of a Single Center 130
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 130
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 130
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 129
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 128
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 128
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 127
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 127
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 127
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 127
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 127
Diagnostic and interventional radiology fundamentals of synovial pathology 127
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 127
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 126
The assessment of atlantoaxial joint involvement in patients with rheumatoid arthritis, results from an observational "real-life" study 126
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 126
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 125
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 124
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 124
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 123
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 123
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 122
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 121
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 121
Diminished expression of the ubiquitin-proteasome system in early treatment-naïve patients with rheumatoid arthritis and concomitant type 2 diabetes may be linked to IL-1 pathway hyper-activity; results from PEAC cohort 120
The specialized pro-resolving lipid mediator Protectin D1 affects macrophages differentiation and activity in Adult-onset Still’s disease and COVID-19, two hyperinflammatory diseases sharing similar transcriptomic profiles 120
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 120
Computed Tomography and MR Imaging in Rheumatoid Arthritis 120
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 120
Interstitial lung disease in systemic sclerosis: current and future treatment. 120
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 119
The effects of suppressing inflammation by tofacitinib may simultaneously improve glycaemic parameters and inflammatory markers in rheumatoid arthritis patients with comorbid type 2 diabetes: a proof-of-concept, open, prospective, clinical study 119
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 119
Il Laboratorio nelle malattie autoimmuni sistemiche 118
The Vessels Contribute to Fibrosis in Systemic Sclerosis 118
Glucocorticoids in Rheumatoid Arthritis: The Silent Companion in the Therapeutic Strategy 118
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 118
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 118
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 117
The joint involvement in adult onset Still's disease is characterised by a peculiar magnetic resonance imaging and a specific transcriptomic profile 116
The administration of methotrexate in patients with Still's disease, “real-life” findings from AIDA Network Still Disease Registry 115
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 115
The reduction of concomitant glucocorticoids dosage following treatment with IL-1 receptor antagonist in adult onset Still's disease. A systematic review and meta-analysis of observational studies 115
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 115
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 114
Totale 13.657
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.006
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.006
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022587 0 0 0 63 17 12 31 42 66 44 61 251
2022/20233.501 226 193 60 362 209 328 49 217 1.676 21 119 41
2023/20241.043 117 46 69 99 76 325 31 54 22 59 41 104
2024/20254.770 118 79 404 213 624 449 575 308 1.120 222 344 314
2025/20269.242 507 918 823 992 887 562 1.572 368 894 1.023 549 147
2026/20273.369 314 361 807 1.887 0 0 0 0 0 0 0 0
Totale 26.147